Is there value in pharmacokinetic-pharmacodynamic modeling of overdose patients? The example of citalopram and QT prolongation
Contribuinte(s) |
E.A. Davis C.G. Sobey |
---|---|
Data(s) |
01/01/2005
|
Identificador | |
Publicador |
ASCEPT |
Palavras-Chave | #EX #320599 Pharmacology not elsewhere classified #730399 Health and support services not elsewhere classified |
Tipo |
Conference Paper |